CUSIP: 25433V105
Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,676,336
-
Share change
-
+118,974
-
Total reported value
-
$169,554,000
-
Price per share
-
$7.83
-
Number of holders
-
39
-
Value change
-
-$1,170,189
-
Number of buys
-
22
-
Number of sells
-
15
Quarterly Holders Quick Answers
What is CUSIP 25433V105?
CUSIP 25433V105 identifies DMTX - DIMENSION THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2016
-
Previous quarter:
Q4 2015
Recent filing periods for CUSIP 25433V105:
Institutional Holders of DIMENSION THERAPEUTICS INC - COM (DMTX) as of Q1 2016
As of 31 Mar 2016,
DIMENSION THERAPEUTICS INC - COM (DMTX) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,676,336 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, New Leaf Venture Partners, L.L.C., RA CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, JANUS CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, Partner Fund Management, L.P., Artal Group S.A., and Rock Springs Capital Management LP.
This page lists
39
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.